Jonathan Bakos
YOU?
Author Swipe
View article: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R Open
Introduction: Most patients diagnosed with primary mediastinal B-cell lymphoma (PMBCL) achieve cure following standard of care therapy with frontline DA-EPOCH-R. However, treatment strategies following relapse after DA-EPOCH-R are not well…
View article: Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World Experience
Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World Experience Open
In a multivariable analysis adjusting for factors including age, race, and comorbidities, HRCAs, non-lenalidomide-based maintenance, non-proteasome inhibitor-based maintenance, and age greater than 65 were associated with inferior PFS. Amo…
View article: Impact of Age, Obesity, and Renal Impairment on Outcomes After Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma
Impact of Age, Obesity, and Renal Impairment on Outcomes After Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma Open
Introduction: High-dose chemotherapy-autologous stem cell transplant (HDT-ASCT) improves both depth and duration of remission for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM). Whether certain subgroups of NDMM …